According to Zeria Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.27. At the end of 2024 the company had a P/S ratio of 1.20.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.20 | 0% |
2023 | 1.20 | -21.97% |
2022 | 1.54 | 3.75% |
2021 | 1.48 | -7.94% |
2020 | 1.61 | 0.42% |
2019 | 1.61 | 3.67% |
2018 | 1.55 | -7.15% |
2017 | 1.67 | 21.41% |
2016 | 1.37 | -0.09% |
2015 | 1.37 | -13.23% |
2014 | 1.58 | -14.19% |
2013 | 1.85 | 71.84% |
2012 | 1.07 | 0.74% |
2011 | 1.07 | 24.07% |
2010 | 0.8596 | 19.8% |
2009 | 0.7176 |